- The FDA approves St. Jude Medical's (NYSE:STJ) Proclaim Elite Spinal Cord Stimulation (SCS) System for the treatment of chronic pain. It is the first upgradeable and recharge-free SCS system cleared in the U.S. The device is also MRI-compatible for head and extremity scans.
- The system features an Apple iPAD mini-based programmer that allows clinicians to program and adjust their patients' SCS therapy. Patients are able to directly assess their therapy with the company's Invisible Trial System, which is a discreet, app-based wireless neuromodulation programming system featured on an Apple iPAD touch mobile device.